...
首页> 外文期刊>Cancer Management and Research >Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
【24h】

Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways

机译:lncRNA OGFRP1的下调通过AKT / mTOR和Wnt /β-catenin信号通路抑制肝癌的进展

获取原文
           

摘要

Introduction: Increasing evidence demonstrates that long noncoding RNAs (lncRNAs) play important roles in the progression of hepatocellular carcinoma (HCC) by regulating gene expression. However, the identification of functional lncRNAs in HCC remains insufficient. Our study aimed to investigate the function of lncRNA OGFRP1, which has not been functionally researched before, in Hep3B and HepG2 cells. Methods: lncRNA OGFRP1 in HCC cells was down-regulated by using RNAi technology. Quantitative real-time polymerase chain reaction was used to determine the mRNA expression of lncRNA OGFRP1. Cell proliferation was examined by CCK8 and clone formation assays. Cell cycle and apoptosis were analyzed by flow cytometry. Cell migration and invasion were assessed by using Scratch assay and transwell assay, respectively. Protein expression of signaling pathways was determined by using Western blot. Results: Cell proliferation of Hep3B was significantly inhibited by down-regulation of lncRNA OGFRP1 ( P <0.05). Moreover, siOGFRP1 transfection induced Hep3B cell cycle arrest and apoptosis by regulating the expression of related proteins. Cell migration and invasion of Hep3B were also significantly inhibited by down-regulation of lncRNA OGFRP1. Wnt/β-catenin signaling pathway, involved in epithelial–mesenchymal transition (EMT), was inactivated by lncRNA OGFRP1 downregulation, including decreased expression of Wnt3a, β-catenin, N-cadherin and vimentin and increased expression of E-cadherin. We also found that the inhibitory effect of lncRNA OGFRP1 knockdown on Hep3B was mediated by the AKT/mTOR signaling pathway and IGF-1, an AKT signaling activator, could rescue the cellular phenotype. However, knockdown of lncRNA OGFRP1 did not influence cell proliferation, migration and invasion in HepG2 cells. Conclusion: We found that downregulation of lncRNA OGFRP1 suppressed the proliferation and EMT of HCC Hep3B cells through AKT and Wnt/β-catenin signaling pathways. However, lncRNA OGFRP1 exhibited a differentiated function in different HCC cell lines, which required further study in the future.
机译:简介:越来越多的证据表明,长的非编码RNA(lncRNA)通过调节基因表达在肝细胞癌(HCC)的进程中发挥重要作用。然而,在肝癌中对功能性lncRNA的鉴定仍然不够。我们的研究旨在研究尚未在功能上研究过的lncRNA OGFRP1在Hep3B和HepG2细胞中的功能。方法:利用RNAi技术下调肝癌细胞中的lncRNA OGFRP1。实时定量聚合酶链反应用于确定lncRNA OGFRP1的mRNA表达。通过CCK8和克隆形成测定法检查细胞增殖。通过流式细胞仪分析细胞周期和凋亡。分别通过使用Scratch测定法和transwell测定法评估细胞迁移和侵袭。通过使用蛋白质印迹法确定信号传导途径的蛋白表达。结果:下调lncRNA OGFRP1可明显抑制Hep3B的细胞增殖(P <0.05)。此外,siOGFRP1转染通过调节相关蛋白的表达诱导Hep3B细胞周期停滞和凋亡。 lncRNA OGFRP1的下调也显着抑制了Hep3B的细胞迁移和侵袭。参与上皮-间质转化(EMT)的Wnt /β-catenin信号通路被lncRNA OGFRP1下调所激活,包括Wnt3a,β-catenin,N-cadherin和波形蛋白的表达降低以及E-cadherin的表达增加。我们还发现,lncRNA OGFRP1敲低对Hep3B的抑制作用是由AKT / mTOR信号通路介导的,而AKT信号激活剂IGF-1可以挽救细胞表型。但是,敲低lncRNA OGFRP1不会影响HepG2细胞中的细胞增殖,迁移和侵袭。结论:我们发现lncRNA OGFRP1的下调通过AKT和Wnt /β-catenin信号通路抑制了HCC Hep3B细胞的增殖和EMT。然而,lncRNA OGFRP1在不同的HCC细胞系中表现出分化的功能,这在未来需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号